Alnylam Pharmaceuticals, Inc. - Common Stock · Transaction Aug 11, 2026 · Filed Sep 9, 2026 · $1,001 to $15,000
XNAS · ALNY
-2.41% · -$5.91 · Vol 2.8M
Market closed · last close 4:00 PM ET · price as of 18:36:29 ET
Alnylam Pharmaceuticals, Inc.
PHARMACEUTICAL PREPARATIONS
$239.60
Follow $ALNY
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $ALNY by emailVeridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredFri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET · ALNY
MethodologyALNY
Alnylam Pharmaceuticals, Inc.
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Middle range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
56/ 100
Veridion Score
Middle range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 6 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is ALNY moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Alnylam Pharmaceuticals, Inc.
PHARMACEUTICAL PREPARATIONSListed since
2004
Employees
3K
Country
US
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam's commercial RNAi therapeutic products include Onpattro and Amvuttra (for hATTR amyloidosis), Givlaari (for acute hepatic porphyria), and Oxlumo (for primary hyperoxaluria type 1), all developed and commercialized by Alnylam. Plus, Leqvio (for hypercholesterolemia) and Qfitlia (for hemophilia A or B), which are being commercialized by Alnylam's partners, Novartis and Sanofi, respectively. It also has several clinical programs across various therapeutic areas, including cardio-metabolic diseases, neuroscience, and hematology.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$246.41
Day high
$246.49
Day low
$238.51
Previous close
$245.51
52W high
$491.22
-51.22% from high
52W low
$205.48
12% of range
Market cap
$32.1B
P/E
99.83×
EPS
$2.40
Beta
-0.37
Shares out
133.8M
Volume
2.8M
1.66× rel vol
Avg volume
1.7M
VWAP
$240.85
Price history computed in-house
1W
-3.65%
1M
+1.43%
3M
-16.34%
1Y
-47.17%
YTD
-39.75%
SMA 50 $247.94 · below
SMA 200 $312.17 · below
52W position 12%
ALNY overview
Related filings and maps
Public disclosures
Congress activity in ALNY
Official filing ↗
Jefferson ShreveSell
ALNY · Transaction May 12, 2025 · Filed Jun 22, 2025 · $15,001 to $50,000
Alnylam Pharmaceuticals, Inc. - Common Stock · Transaction Jan 29, 2024 · Filed Feb 15, 2024 · $1,001 to $15,000
Alnylam Pharmaceuticals, Inc. - Common Stock · Transaction Jan 11, 2024 · Filed Feb 15, 2024 · $1,001 to $15,000
Alnylam Pharmaceuticals, Inc. · Transaction Dec 11, 2023 · Filed Jan 7, 2024 · $1,001 to $15,000
Federal contracts
ALNY contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ALNY in this window.
Lobbying spend
ALNY lobbying filings, year to date.
Registered lobbying filings matched to Alnylam Pharmaceuticals, Inc..
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ALNY in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for ALNY.
Options
Sovereign unlock shows live options positioning for ALNY.